Stem cells for therapy

Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 5, 2013, Pages 223-229

  Rao, Mahendra ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Policy; Regenerative medicine; Regulations; Stem cells

Indexed keywords

ENGINEERING; INDUSTRIAL ENGINEERING; PUBLIC POLICY;

ASIAN CONTINENT; FUNDING MECHANISMS; REGENERATIVE MEDICINE; REGULATIONS; TECHNOLOGICAL BREAKTHROUGHS;

STEM CELLS;

COSMETIC;

ARTICLE; ASIA; BLOOD BANK; COSMETIC INDUSTRY; DRUG APPROVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MEDICAL TOURISM; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; UMBILICAL CORD BLOOD;

EID: 84896718109     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: 10.1007/s13770-013-1081-1     Document Type: Article

References (28)

1. MS Rao, FS Collins, Steering a new course for stem cell research: NIH's Intramural Center for Regenerative Medicine, Stem Cells Transl Med, 1, 15 (2012).
2. M Rao, Public private partnerships: a marriage of necessity, Cell Stem Cell, 12, 149 (2013).
3. JB Gurdon, JA Byrne, The first half-century of nuclear transplantation, Proc Natl Acad Sci USA, 100, 8048 (2003).
4. K Takahashi, K Tanabe, M Ohnuki, et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861 (2007).
5. KR Thomas, MR Capecchi, Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells, Cell, 51, 503 (1987).
6. MR Capecchi, Altering the genome by homologous recombination, Science, 244, 1288 (1989).
7. D Magnus, Translating stem cell research: challenges at the research frontier, J Law Med Ethics, 38, 267 (2010).
8. BP Georgieva, JM Love, Human induced pluripotent stem cells: a review of the US patent landscape, Regen Med, 5, 581 (2010).
9. KT Vrtovec, CT Scott, Patenting pluripotence: the next battle for stem cell intellectual property, Nat Biotechnol, 26, 393 (2008).
10. D Sipp, L Turner, Stem cells. U.S. regulation of stem cells as medical products. Science, 338, 1296 (2012).
11. H Ikegaya, Bioethics: Tighten up Japan's stem-cell practices, Nature, 489, 33 (2012).
12. T Caulfield, A McGuire, Athletes' use of unproven stem cell therapies: adding to inappropriate media hype?, Mol Ther, 20, 1656 (2012).
13. SA Rosenberg, NP Restifo, JC Yang, et al., Adoptive cell transfer: a clinical path to effective cancer immunotherapy, Nat Rev Cancer, 8, 299 (2008).
14. SA Rosenberg SA, BS Packard, PM Aebersold, et al., Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report, N Engl J Med, 319, 1676 (1988).
15. H Zhou, S Chang, M Rao, Human cord blood applications in cell therapy: looking back and look ahead, Expert Opin Biol Ther, 12, 1059 (2012).
16. M Rao, L Ahrlund-Richter, DS Kaufman, Concise review: Cord blood banking, transplantation and induced pluripotent stem cell: success and opportunities, Stem Cells, 30, 55 (2012).
17. M Allison, Hemacord approval may foreshadow regulatory creep for HSC therapies, Nat Biotechnol, 30, 304 (2012).
18. MK Carpenter, LA Couture, Regulatory considerations for the development of autologous induced pluripotent stem cell therapies, Regen Med, 5, 569 (2010).
19. S Kehoe, XF Zhang, D Boyd, FDA approved guidance conduits and wraps for peripheral nerve injury: a review of materials and efficacy, Injury, 43, 553 (2012).
20. AY Chiu, MS Rao, Cell-based therapy for neural disorders- anticipating challenges, Neurotherapeutics, 8, 744 (2011).
21. SU Kim, J de Vellis, Stem cell-based cell therapy in neurological diseases: a review, J Neurosci Res, 87, 2183 (2009).
22. MM Carvalho, FG Teixeira, RL Reis, et al., Mesenchymal stem cells in the umbilical cord: phenotypic characterization, secretome and applications in central nervous system regenerative medicine, Curr Stem Cell Res Ther, 6, 221 (2011).
23. P Zorlutuna, NE Vrana, A Khademhosseini, The expanding world of tissue engineering: the building blocks and new applications of tissue engineered constructs, IEEE Rev Biomed Eng, 6, 47 (2013).
24. R Takagi, M Yamato, N Kanai, et al., Cell sheet technology for regeneration of esophageal mucosa, World J Gastroenterol, 18, 5145 (2012).
25. K Takahashi, K Okita, M Nakagawa, et al., Induction of pluripotent stem cells from fibroblast cultures, Nat Protoc, 2, 3081 (2007).
26. N Malik, MS Rao, A review of the methods for human iPSC derivation, Methods Mol Biol, 997, 23 (2013).
27. J Tan, Y Meng, S Huang, et al., Therapeutic gene products delivery by neuron stem cells, Curr Pharm Biotechnol, 13, 2427 (2012).
28. S Yamanaka, Induced pluripotent stem cells: past, present, and future, Cell Stem Cell, 10, 678 (2012).